# EDGAR Filing Document

**Accession Number:** 0002114460
**File Stem:** 0001104659-26-039298
**Filing Date:** 2026-4
**Character Count:** 24749
**Document Hash:** 98be26f8e09c2bf7fdc5dd836bf948c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-039298.hdr.sgml**: 20260402

**ACCESSION NUMBER**: 0001104659-26-039298

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260402

**DATE AS OF CHANGE**: 20260402

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vivos Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001716166
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 813224056
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92230
- **FILM NUMBER:** 26836034

**BUSINESS ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120
- **BUSINESS PHONE:** (866)908-4867

**MAIL ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vivos BioTechnologies, Inc.
- **DATE OF NAME CHANGE:** 20170901
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** V-Co Investors 3 LLC
- **CENTRAL INDEX KEY:** 0002114460

**ORGANIZATION NAME:**
- **EIN:** 413191504
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 18000 MACK AVENUE
- **CITY:** GROSSE POINTE
- **STATE:** MI
- **ZIP:** 48234
- **BUSINESS PHONE:** 248-723-6650

**MAIL ADDRESS:**
- **STREET 1:** 18000 MACK AVENUE
- **CITY:** GROSSE POINTE
- **STATE:** MI
- **ZIP:** 48234

## Exhibit 99.1

**Exhibit 1**

**JOINT FILING AGREEMENT**

**PURSUANT TO RULE 13d-1(k)**

The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: April 2, 2026

---

| | |
|:---|:---|
|  | V-CO Investors LLC |
| By: | SP Manager LLC, its manager |
|  | /s/ Michael C. Skaff |
| By: | Michael C. Skaff |
| Title: | Managing Director |
|  | V-Co Investors 2 LLC |
| By: | SP Manager LLC, its manager |
|  | /s/ Michael C. Skaff |
| By: | Michael C. Skaff |
| Title: | Managing Director |
|  | V-Co Investors 3 LLC |
| By: | SP Manager LLC, its manager |
|  | /s/ Michael C. Skaff |
| By: | Michael C. Skaff |
| Title: | Managing Director |
|  | SP Manager LLC |
|  | /s/ Michael C. Skaff |
| By: | Michael C. Skaff |
| Title: | Managing Director |
|  | /s/ Michael C. Skaff |
|  | Michael C. Skaff |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Vivos Therapeutics, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Bradley J. Wyatt**<br>Greenberg Traurig LLP<br>2375 E Camelback Road, Suite 800<br>Phoenix AZ 85016<br>602-445-8057

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**03/31/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**V-CO Investors LLC** | Name of reporting person<br>**V-CO Investors LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**WYOMING** | Citizenship or place of organization<br>**WYOMING** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**514498.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**514498.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**514498.00** | Aggregate amount beneficially owned by each reporting person<br>**514498.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**3.8%** | Percent of class represented by amount in Row (11)<br>**3.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026 in connection with a private financing between V-Co Investors 3 LLC and the Company.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**V-Co Investors 2 LLC** | Name of reporting person<br>**V-Co Investors 2 LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**WYOMING** | Citizenship or place of organization<br>**WYOMING** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**828000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**828000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**828000.00** | Aggregate amount beneficially owned by each reporting person<br>**828000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.1%** | Percent of class represented by amount in Row (11)<br>**6.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026 in connection with a private financing between V-Co Investors 3 LLC and the Issuer.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**V-Co Investors 3 LLC** | Name of reporting person<br>**V-Co Investors 3 LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**WYOMING** | Citizenship or place of organization<br>**WYOMING** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1353625.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1353625.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1353625.00** | Aggregate amount beneficially owned by each reporting person<br>**1353625.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10%** | Percent of class represented by amount in Row (11)<br>**10%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026 in connection with a private financing between V-Co Investors 3 LLC and the Issuer.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**SP Manager LLC** | Name of reporting person<br>**SP Manager LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**WYOMING** | Citizenship or place of organization<br>**WYOMING** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**2696123.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**2696123.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2696123.00** | Aggregate amount beneficially owned by each reporting person<br>**2696123.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.9%** | Percent of class represented by amount in Row (11)<br>**19.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026 in connection with a private financing between V-Co Investors 3 LLC and the Issuer.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Michael C. Skaff** | Name of reporting person<br>**Michael C. Skaff** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**2696123.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**2696123.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2696123.00** | Aggregate amount beneficially owned by each reporting person<br>**2696123.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.9%** | Percent of class represented by amount in Row (11)<br>**19.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The percentage is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026 in connection with a private financing between V-Co Investors 3 LLC and the Issuer.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Vivos Therapeutics, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
7921 SOUTHPARK PLAZA, SUITE 210, LITTLETON, CO, 80120

**Item 4. Purpose of Transaction**

The Reporting Person's purpose of acquiring these securities is for investment purposes. The Reporting Person intends to engage, or has engaged, in discussions with the Issuer and its management and/or board of directors regarding the Issuer's financial performance, strategic direction, operational matters, and corporate governance practices. On March 31, 2026, the Issuer and V-Co 3 entered into a Securities Purchase Agreement where the Issuer sold to V-Co 3 in a private placement: (i) 1,353,625 shares of Common Stock ("PIPE Common Stock"), (ii) a Series A Common Stock Purchase Warrant ("Series A Warrant") to purchase up to 1,783,582 shares of Common Stock ("Warrant Shares"), (iii) a Series B Common Stock Purchase Warrant ("Series B Purchase Warrant" and together with the Series A Warrant, the "Common Stock Warrants") to purchase up to 1,783,582 Warrant Shares and (iv) a Pre-Funded Warrant ("Pre-Funded Warrant") to purchase up to 429,957 shares of Common Stock ("PFW Shares," together with the PIPE Common Stock and Warrant Shares, the "Shares"). In compliance with the listing rules of the Nasdaq Stock Market LLC, V-Co 3 purchased the Shares at a purchase price of $1.34 per share. The Series A Warrant is immediately exercisable with a two-year term from the date of purchase and has an exercise price of $1.09 per share. The Series B Warrant is immediately exercisable with a five-year term from the date of purchase and has an exercise price of $1.09 per share. Similarly, the Pre-Funded Warrant is immediately exercisable and has an exercise price of $0.0001 per share. V-Co 3 is prohibited from exercising such Common Stock Warrants and Pre-Funded Warrant if it results in V-Co 3 or its affiliates owning in excess of 19.99% of the then outstanding Common Stock of the Issuer. The purpose of the private placement was for general working capital purposes.

Other than as described above, the Reporting Persons do not have any current plans or proposals which relate to, or would result in, (a) any acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;(c) any sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940; (g) any change in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) any action similar to any of those enumerated above.

**Item 5. Interest in Securities of the Issuer**

**(a)**
V-CO directly holds 514,498 shares, which represents 3.8% of Common Stock of the Issuer; V-Co 2 directly holds 828,000 shares, which represents 6.1% of the Common Stock of the Issuer; V-Co 3 directly holds 1,353,625 shares, which represents 10.0% of the Common Stock of the Issuer; the Manager may be deemed to beneficially own an aggregate of 2,696,123 shares, which represents 19.9% of Common Stock of the Issuer by virtue of its capacity as manager of V-CO, V-Co 2 and V-Co 3; and Mr. Skaff may be deemed to beneficially own 2,696,123 shares, which represents 19.9% of Common Stock of the Issuer by virtue of his capacity as managing director of the Manager.

The percentage of class of securities identified is calculated based upon (i) 12,132,381 shares of Common Stock issued and outstanding as of March 31, 2026, as reported by the Issuer, plus (ii) 1,353,625 shares of Common Stock issued to V-Co Investors 3 LLC on March 31, 2026, in connection with a private financing between V-Co Investors 3 LLC and the Issuer. The foregoing excludes (i) 3,220,266 shares of Common Stock issuable to V-CO upon the exercise of certain common stock warrants; and (ii) 2,705,768 shares issuable to V-CO upon the exercise of certain pre-funded warrants.  The foregoing also excludes (i) 2,329,886 shares of Common Stock issuable to V-Co 2 upon the exercise of certain common stock warrants; and (ii) 725,258 shares of Common Stock issuable to V-Co 2 upon the exercise of certain pre-funded warrants. The foregoing further excludes (i) 429,957 shares of Common Stock issuable to V-Co 3 upon exercise of the Pre-Funded Warrant; (ii) 1,783,582 shares of Common Stock issuable to V-Co 3 upon exercise of the Series A Warrant; and (iii) 1,783,582 shares of Common Stock issuable to V-Co 3 upon exercise of the Series B Warrant. Each of these are excluded due to a blocker provision under which the holder thereof does not have the right to exercise any of the foregoing to the extent that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 19.99% of the Common Stock. Without such blocker provisions, V-CO may be deemed to have beneficial ownership of an additional 5,926,034 shares; V-Co 2 may be deemed to have beneficial ownership of an additional 3,055,144 shares; V-Co 3 may be deemed to have beneficial ownership over an additional 3,997,121 shares; and SP Manager LLC, and Michael C. Skaff may have been deemed to have beneficial ownership of an additional 12,978,299 shares.

**(b)**
V-CO has shared voting power and dispositive power over 514,498 shares of Common Stock of the Issuer. V-Co 2 has shared voting power and dispositive power over 828,000 shares of Common Stock of the Issuer. V-Co 3 has shared voting power and dispositive power over 1,353,625 shares of Common Stock of the Issuer. Both the Manager and Mr. Skaff have shared voting power and dispositive power over 2,696,123 shares of Common Stock of the Issuer. The Manager and Mr. Skaff disclaim beneficial ownership over the shares of Common Stock directly held by V-CO, V-Co 2 and V-Co 3, except to the extent of their respective pecuniary interest therein.

**(c)**
Other than as described in Item 4 above, none of the other Reporting Persons effected any transactions in shares of Common Stock of the Issuer during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

To the knowledge, of the Reporting Persons, there is no contract, arrangement, understanding or relationship (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any other person with respect to any securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** V-CO Investors LLC

**Signature:** Michael C. Skaff

**Name/Title:** Michael C. Skaff, Managing Director of SP Manager LLC, its Manager

**Date:** 04/02/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** V-Co Investors 2 LLC

**Signature:** Michael C. Skaff

**Name/Title:** Michael C. Skaff, Managing Director of SP Manager LLC, its Manager

**Date:** 04/02/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** V-Co Investors 3 LLC

**Signature:** Michael C. Skaff

**Name/Title:** Michael C. Skaff, Managing Director of SP Manager LLC, its Manager

**Date:** 04/02/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** SP Manager LLC

**Signature:** Michael C. Skaff*

**Name/Title:** Michael C. Skaff, Managing Director

**Date:** 04/02/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Michael C. Skaff

**Signature:** Michael C. Skaff*

**Name/Title:** Michael C. Skaff, Managing Director

**Date:** 04/02/2026